Skip to main content

An extended APOBEC3A mutation signature in cancer.

Publication ,  Journal Article
Langenbucher, A; Bowen, D; Sakhtemani, R; Bournique, E; Wise, JF; Zou, L; Bhagwat, AS; Buisson, R; Lawrence, MS
Published in: Nat Commun
March 11, 2021

APOBEC mutagenesis, a major driver of cancer evolution, is known for targeting TpC sites in DNA. Recently, we showed that APOBEC3A (A3A) targets DNA hairpin loops. Here, we show that DNA secondary structure is in fact an orthogonal influence on A3A substrate optimality and, surprisingly, can override the TpC sequence preference. VpC (non-TpC) sites in optimal hairpins can outperform TpC sites as mutational hotspots. This expanded understanding of APOBEC mutagenesis illuminates the genomic Twin Paradox, a puzzling pattern of closely spaced mutation hotspots in cancer genomes, in which one is a canonical TpC site but the other is a VpC site, and double mutants are seen only in trans, suggesting a two-hit driver event. Our results clarify this paradox, revealing that both hotspots in these twins are optimal A3A substrates. Our findings reshape the notion of a mutation signature, highlighting the additive roles played by DNA sequence and DNA structure.

Duke Scholars

Published In

Nat Commun

DOI

EISSN

2041-1723

Publication Date

March 11, 2021

Volume

12

Issue

1

Start / End Page

1602

Location

England

Related Subject Headings

  • Proteins
  • Nucleic Acid Conformation
  • Neoplasms
  • Mutation
  • Mutagenesis
  • Minor Histocompatibility Antigens
  • Humans
  • HEK293 Cells
  • Escherichia coli
  • DNA
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Langenbucher, A., Bowen, D., Sakhtemani, R., Bournique, E., Wise, J. F., Zou, L., … Lawrence, M. S. (2021). An extended APOBEC3A mutation signature in cancer. Nat Commun, 12(1), 1602. https://doi.org/10.1038/s41467-021-21891-0
Langenbucher, Adam, Danae Bowen, Ramin Sakhtemani, Elodie Bournique, Jillian F. Wise, Lee Zou, Ashok S. Bhagwat, Rémi Buisson, and Michael S. Lawrence. “An extended APOBEC3A mutation signature in cancer.Nat Commun 12, no. 1 (March 11, 2021): 1602. https://doi.org/10.1038/s41467-021-21891-0.
Langenbucher A, Bowen D, Sakhtemani R, Bournique E, Wise JF, Zou L, et al. An extended APOBEC3A mutation signature in cancer. Nat Commun. 2021 Mar 11;12(1):1602.
Langenbucher, Adam, et al. “An extended APOBEC3A mutation signature in cancer.Nat Commun, vol. 12, no. 1, Mar. 2021, p. 1602. Pubmed, doi:10.1038/s41467-021-21891-0.
Langenbucher A, Bowen D, Sakhtemani R, Bournique E, Wise JF, Zou L, Bhagwat AS, Buisson R, Lawrence MS. An extended APOBEC3A mutation signature in cancer. Nat Commun. 2021 Mar 11;12(1):1602.

Published In

Nat Commun

DOI

EISSN

2041-1723

Publication Date

March 11, 2021

Volume

12

Issue

1

Start / End Page

1602

Location

England

Related Subject Headings

  • Proteins
  • Nucleic Acid Conformation
  • Neoplasms
  • Mutation
  • Mutagenesis
  • Minor Histocompatibility Antigens
  • Humans
  • HEK293 Cells
  • Escherichia coli
  • DNA